Coppell Advisory Solutions’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-160
Closed -$6.04K 508
2024
Q4
$6.04K Hold
160
﹤0.01% 1277
2024
Q3
$6.67K Hold
160
﹤0.01% 1196
2024
Q2
$6.54K Buy
+160
New +$6.37K ﹤0.01% 1131
2023
Q4
$6.47K Hold
160
﹤0.01% 1049
2023
Q3
$6.97K Hold
160
﹤0.01% 669
2023
Q2
$6.44K Buy
+160
New +$6.58K ﹤0.01% 796
2023
Q1
Sell
-160
Closed -$6.97K 296
2022
Q4
$6.97K Buy
+160
New +$6.8K ﹤0.01% 673

Other funds holding BME

Coppell Advisory Solutions's BME Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of BlackRock Health Sciences Trust (BME) in Q1 2025, closing a stake of 160 shares — an estimated $6.04K sold.

Coppell Advisory Solutions first reported a position in BME in Q4 2022 and held it in 7 quarters. The position peaked at $6.97K in Q3 2023. 67 funds tracked by Wall St. Rank hold BME as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining BlackRock Health Sciences Trust position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 160 BlackRock Health Sciences Trust shares in Q1 2025, an estimated $6.04K.
  • Coppell Advisory Solutions first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 7 quarters.
  • Coppell Advisory Solutions's BlackRock Health Sciences Trust position peaked at $6.97K in Q3 2023.
  • 67 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.